Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
1.
J Cell Mol Med ; 24(22): 13408-13420, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33043579

RESUMEN

Endoplasmic reticulum (ER) stress and inflammatory responses play active roles in the transition of acute kidney injury (AKI) to chronic kidney disease (CKD). Inositol-requiring enzyme 1 (IRE1) activates c-Jun NH2 -terminal kinase (JNK) in ER stress. Tubular epithelial cells (TEC) are the main injury target and source of AKI inflammatory mediators. TEC injury may lead to glomerulosclerosis, however, the underlying mechanism remains unclear. Here, hypoxia/reoxygenation (H/R) HK-2 cells were used as an AKI model. To determine the partial effects of TEC injury on the glomerulus, HK-2 cells after H/R were co-cultured with human renal mesangial cells (HRMC). H/R up-regulated ER stress, IRE1/JNK pathway, IL-6 and MCP-1 in HK-2 cells. Stimulation of HRMC with IL-6 enhanced their proliferation and the expression of glomerulosclerosis-associated fibronectin and collagen IV via signal transducer and activator of transcription 3 (STAT3) activation. Similar responses were observed in HRMC co-cultured with HK-2 cells after H/R. IRE1/JNK inhibition reversed these injury responses in HRMC. IRE1/JNK stable knock-down in HK-2 cells and shRNA-mediated STAT3 depletion in HRMC confirmed their role in inflammation/glomerulosclerosis. These findings suggest that IRE1/JNK pathway mediates inflammation in TEC, affecting mesangial cells. The inhibition of this pathway could be a feasible approach to prevent AKI-CKD transition.


Asunto(s)
Hipoxia de la Célula , Endorribonucleasas/metabolismo , Matriz Extracelular/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Células Mesangiales/metabolismo , Oxígeno/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Transducción de Señal/efectos de los fármacos , Lesión Renal Aguda/etiología , Lesión Renal Aguda/metabolismo , Lesión Renal Aguda/patología , Biomarcadores , Citocinas/metabolismo , Progresión de la Enfermedad , Susceptibilidad a Enfermedades , Estrés del Retículo Endoplásmico , Técnica del Anticuerpo Fluorescente , Técnicas de Silenciamiento del Gen , Humanos , Mediadores de Inflamación/metabolismo , Células Mesangiales/ultraestructura , ARN Interferente Pequeño/genética , Insuficiencia Renal Crónica/etiología , Insuficiencia Renal Crónica/metabolismo , Insuficiencia Renal Crónica/patología , Factor de Transcripción STAT3/metabolismo , Factor de Transcripción CHOP/metabolismo
2.
CEN Case Rep ; 9(4): 359-364, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32388829

RESUMEN

A 52-year-old woman was diagnosed with chronic myeloid leukemia. Treatment with dasatinib, a second-generation Bcr-Abl tyrosine kinase inhibitor, was initiated, and complete cytogenetic remission was achieved. Two years later, proteinuria occurred, and the urinary protein level increased gradually in the next 3 years. Moreover, the serum creatinine level increased mildly during this period. The urinary protein level reached 2.18 g/gCr; hence, a renal biopsy was conducted. Light microscopy revealed mild proliferation of mesangial cells, and immunofluorescence analysis revealed IgG and C3 depositions in the mesangial area. Electron microscopy revealed electron-dense deposition in the paramesangial area, partial podocyte foot process effacement, and segmental endothelial cell swelling with a slight expansion of the subendothelial space. Dasatinib was discontinued, and within 3 weeks, the proteinuria disappeared, with improvements in her renal function. After switching to bosutinib, a new second-generation of tyrosine kinase inhibitor, the proteinuria remained negative. The rapid cessation of proteinuria following dasatinib discontinuation indicated that proteinuria was induced by the long-term administration of dasatinib. Proteinuria and renal function should be regularly monitored during dasatinib therapy.


Asunto(s)
Dasatinib/efectos adversos , Glomérulos Renales/lesiones , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/efectos adversos , Proteinuria/inducido químicamente , Compuestos de Anilina/uso terapéutico , Biopsia , Creatinina/sangre , Dasatinib/uso terapéutico , Sustitución de Medicamentos , Femenino , Técnica del Anticuerpo Fluorescente/métodos , Humanos , Riñón/patología , Glomérulos Renales/efectos de los fármacos , Leucemia Mielógena Crónica BCR-ABL Positiva/diagnóstico , Células Mesangiales/efectos de los fármacos , Células Mesangiales/metabolismo , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Microscopía Electrónica/métodos , Persona de Mediana Edad , Nitrilos/uso terapéutico , Inhibidores de Proteínas Quinasas/uso terapéutico , Quinolinas/uso terapéutico , Inducción de Remisión , Resultado del Tratamiento , Privación de Tratamiento
3.
Int J Med Sci ; 17(8): 1056-1061, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32410835

RESUMEN

The aim of this study was to determine whether interleukin-1ß (IL-1ß) promotes oxidised low-density lipoprotein (Ox-LDL) uptake by human glomerular mesangial cells (HMCs) and its effect on the expression of lectin-like Ox-LDL receptor 1 (LOX-1) and to identify pathways through which IL-1ß affects lipid uptake. Confocal laser scanning microscopy and flow cytometry were used to observe the effect of IL-1ß on lipid uptake by HMCs and the pathway by which IL-1ß may mediate lipid uptake. Real-time polymerase chain reaction (PCR) and western blotting were used to evaluate the effect of IL-1ß on LOX-1 expression. Confocal laser scanning microscopy and flow cytometry revealed that IL-1ß promoted uptake of fluorescent Dil-labelled Ox-LDL(Dil-Ox-LDL) by HMCs and the enhanced uptake of Dil-Ox-LDL was partially inhibited by an anti-LOX-1 antibody evaluated by flow cytometry. Further, IL-1ß promoted LOX-1 mRNA and protein expression of HMCs in a dose- and time-dependent manner. Thus, Ox-LDL is ingested by HMCs under basic conditions. Inflammatory cytokine IL-1ß promotes Ox-LDL uptake by HMCs. Furthermore, IL-1ß promotes the mRNA and protein expression of LOX-1, a specific receptor of Ox-LDL, suggesting that the enhancement of Ox-LDL uptake may be mediated by LOX-1 pathway. Anti-LOX-1 therapy may be a promising option for treatment of glomerulosclerosis.


Asunto(s)
Interleucina-1beta/metabolismo , Lipoproteínas LDL/metabolismo , Células Mesangiales/metabolismo , Receptores Depuradores de Clase E/metabolismo , Línea Celular , Nefropatías Diabéticas/tratamiento farmacológico , Nefropatías Diabéticas/inmunología , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/patología , Citometría de Flujo , Humanos , Metabolismo de los Lípidos/efectos de los fármacos , Metabolismo de los Lípidos/inmunología , Células Mesangiales/inmunología , Células Mesangiales/ultraestructura , Microscopía Confocal , Receptores Depuradores de Clase E/antagonistas & inhibidores
4.
Int J Mol Sci ; 20(21)2019 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-31661773

RESUMEN

The alteration of mesangial matrix (MM) components in mesangium, such as type IV collagen (COL4) and type I collagen (COL1), is commonly found in progressive glomerular disease. Mesangial cells (MCs) responding to altered MM, show critical changes in cell function. This suggests that the diseased MM structure could play an important role in MC behavior. To investigate how MC behavior is influenced by the diseased MM 3D nanostructure, we fabricated the titanium dioxide (TiO2)-based nanopatterns that mimic diseased MM nanostructures. Immortalized mouse MCs were used to assess the influence of disease-mimic nanopatterns on cell functions, and were compared with a normal-mimic nanopattern. The results showed that the disease-mimic nanopattern induced disease-like behavior, including increased proliferation, excessive production of abnormal MM components (COL1 and fibronectin) and decreased normal MM components (COL4 and laminin α1). In contrast, the normal-mimic nanopattern actually resulted in cells displaying normal proliferation and the production of normal MM components. In addition, increased expressions of α-smooth muscle actin (α-SMA), transforming growth factor ß1 (TGF-ß1) and integrin α5ß1 were detected in cells grown on the disease-mimic nanopattern. These results indicated that the disease-mimic nanopattern induced disease-like cell behavior. These findings will help further establish a disease model that mimics abnormal MM nanostructures and also to elucidate the molecular mechanisms underlying glomerular disease.


Asunto(s)
Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Células Mesangiales/citología , Células Mesangiales/metabolismo , Actinas/metabolismo , Animales , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Colágeno Tipo I/metabolismo , Colágeno Tipo IV/metabolismo , Fibronectinas/metabolismo , Mesangio Glomerular/citología , Integrinas/metabolismo , Laminina/metabolismo , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Ratones , Nanoestructuras/química , Nanoestructuras/toxicidad , Nanoestructuras/ultraestructura , Titanio/química , Factor de Crecimiento Transformador beta/metabolismo
5.
Int J Nanomedicine ; 14: 3995-4005, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31213811

RESUMEN

Purpose: Since nanoparticles (NPs) are beginning to be introduced in medicine and industry, it is mendatory to evaluate their biological side-effects, among other things. The present study aimed to investigate the pathways by which nickel nanoparticles (NiNPs) enter nephrons and to evaluate their localization and effects on cellular ultrastructure. Methods: Rats were injected intraperitoneally with 20 nm NiNPs (20 mg/Kg/b.w./day) for 28 consecutive days. Transmission electron microscope technique was used to detect localization of NiNPs and their effects on cellular ultrastructure in rat kidneys. Additionally, measurements of certain biochemical parameters such as creatinine, urea, uric acid and phosphorus for investigating renal function following NiNPs treatment were taken. Results: The presence of NiNPs in the nephrons in treated rats was confirmed by transmission electron microscopy. NiNPs entered the renal tubules cells via various pathways. The results indicated that NiNPs administration induced ultrastructural changes in the proximal cells of renal tubules and certain glomerular cells (podocytes and mesangial cells). Additionally, NiNPs were found to be localized in the mitochondria, which led to a significant decrease in their density and morphology. Furthermore, cell death was induced in the glomerular cells as found with a Terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) assay and through detection of p35 using immunohistochemical staining. Conclusion: Herein, NiNPs were found to induce various cellular ultrastructural changes in the kidneys of rats. NiNPs used diverse pathways to internalize into the cytoplasm of the proximal convoluted tubules (PT) cells across the basement membrane, and also through the plasma membrane of two adjacent PT cells. NiNPs internalization, accumulation and their alterations of the cellular ultrastructure affected rat renal function.


Asunto(s)
Endocitosis , Riñón/ultraestructura , Nanopartículas del Metal/ultraestructura , Animales , Células Epiteliales/ultraestructura , Masculino , Células Mesangiales/ultraestructura , Mitocondrias/ultraestructura , Níquel/química , Tamaño de la Partícula , Podocitos/ultraestructura , Ratas Wistar
6.
J Cell Mol Med ; 23(8): 5654-5671, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31184423

RESUMEN

Mesangioproliferative glomerulonephritis (MsPGN) is characterized by the proliferation of glomerular mesangial cells (GMCs) and accumulation of extracellular matrix (ECM), followed by glomerulosclerosis and renal failure of patients. Although our previous studies have demonstrated that sublytic C5b-9 complex formed on the GMC membrane could trigger GMC proliferation and ECM expansion of rat Thy-1 nephritis (Thy-1N) as an animal model of MsPGN, their mechanisms are still not fully elucidated. In the present studies, we found that the levels of response gene to complement 32 (RGC-32), myeloid zinc finger 1 (MZF1), phosphorylated extracellular signal-regulated kinase 5 (phosphorylated ERK5, p-ERK5), F-box only protein 28 (FBXO28) and TNF receptor-associated factor 6 (TRAF6) were all markedly up-regulated both in the renal tissues of rats with Thy-1N (in vivo) and in the GMCs upon sublytic C5b-9 stimulation (in vitro). Further in vitro experiments revealed that up-regulated FBXO28 and TRAF6 could form protein complex binding to ERK5 and enhance ERK5 K63-ubiquitination and subsequent phosphorylation. Subsequently, ERK5 activation contributed to MZF1 expression and MZF1-dependent RGC-32 up-regulation, finally resulting in GMC proliferative response. Furthermore, the MZF1-binding element within RGC-32 promoter and the functions of FBXO28 domains were identified. Additionally, knockdown of renal FBXO28, TRAF6, ERK5, MZF1 and RGC-32 genes respectively markedly reduced GMC proliferation and ECM production in Thy-1N rats. Together, these findings indicate that sublytic C5b-9 induces GMC proliferative changes in rat Thy-1N through ERK5/MZF1/RGC-32 axis activated by the FBXO28-TRAF6 complex, which might provide a new insight into MsPGN pathogenesis.


Asunto(s)
Proteínas de Ciclo Celular/metabolismo , Complejo de Ataque a Membrana del Sistema Complemento/metabolismo , Células Mesangiales/citología , Células Mesangiales/metabolismo , Proteína Quinasa 7 Activada por Mitógenos/metabolismo , Proteínas Musculares/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Proteínas Ligasas SKP Cullina F-box/metabolismo , Factor 6 Asociado a Receptor de TNF/metabolismo , Transactivadores/metabolismo , Animales , Proliferación Celular , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestructura , Lisina/metabolismo , Masculino , Células Mesangiales/ultraestructura , Regiones Promotoras Genéticas/genética , Ratas Sprague-Dawley , Transducción de Señal , Antígenos Thy-1 , Transactivadores/genética , Transcripción Genética , Ubiquitinación
7.
Clin Exp Nephrol ; 23(6): 773-781, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30734164

RESUMEN

BACKGROUND: The interaction among the glomerular components plays an important role in the development of glomerular lesions; thus, investigation of the ultrastructural three-dimensional (3D) configuration of the human glomerular cells and extracellular matrix (ECM) is important for understanding the pathogenesis of glomerulosclerosis, especially glomerulonephritis. METHODS: We applied a new technique of serial block-face scanning electron microscopy (SBF-SEM), which helps to acquire serial electron microscopic images to reconstruct a 3D ultrastructure, to a human kidney biopsy specimen obtained from a 25-year-old woman with lupus nephritis. RESULTS: SBF-SEM demonstrated that the cytoplasmic processes of the podocyte penetrated into the lamina densa of the glomerular basement membrane, and was in direct contact with the cytoplasm of mesangial cells at the site of mesangial interposition. CONCLUSION: Although this is a single-case observational study, SBF-SEM revealed a unique 3D configuration, suggesting a novel mechanism of direct intercellular cross-communication between podocytes and mesangial cells, aside from the presumed paracrine communication.


Asunto(s)
Membrana Basal Glomerular/ultraestructura , Nefritis Lúpica/patología , Células Mesangiales/ultraestructura , Podocitos/ultraestructura , Adulto , Femenino , Humanos , Imagenología Tridimensional , Microscopía Electrónica de Rastreo/métodos
8.
BMC Nephrol ; 19(1): 350, 2018 12 10.
Artículo en Inglés | MEDLINE | ID: mdl-30526529

RESUMEN

BACKGROUND: Maternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal manifestations precede other key clinical features such as diabetes and deafness and/or when the disease is complicated by other renal pathologies. CASE PRESENTATION: Here, we present the case of a 33-year-old Japanese woman who had initially been diagnosed with IgA nephropathy but was found to have MIDD 6 years later. Two renal biopsies were conducted six years apart. While assessment of the first biopsy specimen with the monoclonal antibody (KM55) revealed mesangial IgA deposits (containing the galactose-deficient IgA1 variant [Gd-IgA1]), examination of the second specimen showed no mesangial IgA deposits and newly-developed glomerular global scleroses and tubular damage. Granular swollen epithelial cells (GSECs), characterised by abnormal mitochondria, were observed among the tubules and collecting ducts in both biopsy specimens. Mitochondrial DNA analysis revealed an m.3243A > G mutation. CONCLUSIONS: We rediscovered the usefulness of GSECs as a pathologically distinctive feature of mitochondrial nephropathy and reviewed the literature regarding MIDD complicated by mesangial IgA deposition. Furthermore, we demonstrate that the mesangial IgA deposits in this patient consisted of the galactose-deficient IgA1 variant. The monoclonal antibody (KM55) might be a useful tool to distinguish IgAN from latent IgA deposits.


Asunto(s)
Sordera/complicaciones , Sordera/diagnóstico , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/diagnóstico , Galactosa/deficiencia , Inmunoglobulina A/análisis , Células Mesangiales/patología , Enfermedades Mitocondriales/complicaciones , Enfermedades Mitocondriales/diagnóstico , Adulto , Sordera/genética , Diabetes Mellitus Tipo 2/genética , Femenino , Humanos , Células Mesangiales/química , Células Mesangiales/ultraestructura , Enfermedades Mitocondriales/genética , Linaje
9.
BMC Nephrol ; 19(1): 53, 2018 03 06.
Artículo en Inglés | MEDLINE | ID: mdl-29510679

RESUMEN

BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed acute renal injury with proteinuria after CM administration. To our surprise, in his renal biopsy sample the myelin figure like structure was observed in glomerular endothelium and mesangial cells by transmission electron microscopy. However the patient didn't has any clinic clues of Fabry disease and other lysosomal storage disorders. Moreover in vitro cultured glomerular endothelial and mesangial cells we found CM triggers lipid aggregation along with the increased CD36 and decreased ABCA1 abundance. Thus this patient was administrated statin to correct the aberrant lipid trafficking, 2 months later at his next visit we found his renal function partially recovered with reduced proteinuria. CONCLUSIONS: Besides the well-known underlying mechanisms, CM may cause renal impairment by triggering the dysregulated transportation of lipid. Furthermore statin is suggested to be a very promising medicine to decrease side effects of CM.


Asunto(s)
Lesión Renal Aguda/inducido químicamente , Medios de Contraste/efectos adversos , Glomérulos Renales/efectos de los fármacos , Lipidosis/inducido químicamente , Células Mesangiales/efectos de los fármacos , Lesión Renal Aguda/patología , Humanos , Glomérulos Renales/patología , Glomérulos Renales/ultraestructura , Lipidosis/patología , Masculino , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Persona de Mediana Edad
10.
Diabetes ; 67(5): 986-993, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29490904

RESUMEN

Diabetic nephropathy (DN) is the major cause of end-stage kidney disease, but early biomarkers of DN risk are limited. Herein we examine urinary IgG4 and Smad1 as additional early DN biomarkers. We recruited 815 patients with type 2 diabetes; 554 patients fulfilled the criteria of an estimated glomerular filtration rate (eGFR) >60 mL/min and no macroalbuminuria at baseline, with follow-up for 5 years. Patients without macroalbuminuria were also recruited for renal biopsies. Urinary IgG4 and Smad1 were determined by enzyme-linked immunoassays using specific antibodies. The specificity, sensitivity, and reproducibility were confirmed for each assay. Increased urinary IgG4 was significantly associated with lower eGFR. The level of urinary IgG4 also significantly correlated with surface density of peripheral glomerular basement membrane (Sv PGBM/Glom), whereas Smad1 was associated with the degree of mesangial expansion-both classic pathological findings in DN. Baseline eGFR did not differ between any groups; however, increases in both urinary IgG4 and Smad1 levels at baseline significantly predicted later development of eGFR decline in patients without macroalbuminuria. These data suggest that urinary IgG4 and Smad1 at relatively early stages of DN reflect underlying DN lesions and are relevant to later clinical outcomes.


Asunto(s)
Diabetes Mellitus Tipo 2/orina , Nefropatías Diabéticas/orina , Inmunoglobulina G/orina , Riñón/patología , Proteína Smad1/orina , Adulto , Biomarcadores/orina , Diabetes Mellitus Tipo 2/complicaciones , Nefropatías Diabéticas/diagnóstico , Nefropatías Diabéticas/etiología , Nefropatías Diabéticas/patología , Diagnóstico Precoz , Ensayo de Inmunoadsorción Enzimática , Femenino , Membrana Basal Glomerular/ultraestructura , Tasa de Filtración Glomerular , Humanos , Masculino , Células Mesangiales/ultraestructura , Microscopía Electrónica , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
11.
Eur J Nutr ; 57(2): 761-772, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28004272

RESUMEN

INTRODUCTION: Diabetic nephropathy (DN) is an important microvascular complication of uncontrolled diabetes. The features of DN include albuminuria, extracellular matrix alterations, and progressive renal insufficiency. Rice bran protein hydrolysates (RBPs) have been reported to have antihyperglycemic, lipid-lowering, and anti-inflammatory effects in diabetic rats. Our study was to investigate the renoprotective effects of RBP in diabetic animals and mesangial cultured cells. METHODS: Eight-week-old male db/m and db/db mice were orally treated with tap water or RBP (100 or 500 mg/kg/day) for 8 weeks. At the end of the experiment, diabetic nephropathy in kidney tissues was investigated for histological, ultrastructural, and clinical chemistry changes, and biomarkers of angiogenesis, fibrosis, inflammation, and antioxidant in kidney were analyzed by Western blotting. Protection against proangiogenic proteins and induction of cytoprotection by RBP in cultured mesangial cells was evaluated. RESULTS: RBP treatment improved insulin sensitivity, decreased elevated fasting serum glucose levels, and improved serum lipid levels and urinary albumin/creatinine ratios in diabetic mice. RBP ameliorated the decreases in podocyte slit pore numbers, thickening of glomerular basement membranes, and mesangial matrix expansion and suppressed elevation of MCP-1, ICAM-1, HIF-1α, VEGF, TGF-ß, p-Smad2/3, and type IV collagen expression. Moreover, RBP restored suppressed antioxidant Nrf2 and HO-1 expression. In cultured mesangial cells, RBP inhibited high glucose-induced angiogenic protein expression and induced the expression of Nrf2 and HO-1. CONCLUSION: RBP attenuates the progression of diabetic nephropathy and restored renal function by suppressing the expression of proangiogenic and profibrotic proteins, inhibiting proinflammatory mediators, and restoring the antioxidant and cytoprotective system.


Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Nefropatías Diabéticas/prevención & control , Hipoglucemiantes/uso terapéutico , Resistencia a la Insulina , Oryza/química , Proteínas de Vegetales Comestibles/uso terapéutico , Hidrolisados de Proteína/uso terapéutico , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Línea Celular , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/patología , Nefropatías Diabéticas/inmunología , Industria de Procesamiento de Alimentos/economía , Hiperglucemia/prevención & control , Hipoglucemiantes/economía , Hipoglucemiantes/metabolismo , Residuos Industriales/análisis , Residuos Industriales/economía , Riñón/inmunología , Riñón/metabolismo , Riñón/patología , Riñón/ultraestructura , Masculino , Células Mesangiales/inmunología , Células Mesangiales/metabolismo , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Ratones Mutantes , Microscopía Electrónica de Transmisión , Epidermis de la Planta/química , Proteínas de Vegetales Comestibles/economía , Proteínas de Vegetales Comestibles/metabolismo , Hidrolisados de Proteína/economía , Hidrolisados de Proteína/metabolismo , Insuficiencia Renal/complicaciones , Insuficiencia Renal/inmunología , Insuficiencia Renal/prevención & control , Semillas/química , Tailandia
12.
Bull Exp Biol Med ; 164(2): 218-222, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29177881

RESUMEN

The ultrastructure of nephrocytes of the proximal and distal convoluted tubules, podocytes, mesangial cells, and macrophages of the interstitial connective tissue was studied after single intravenous administration of magnetite nanoparticles modified with chitosan (magnetic nanospheres) or lipids (magnetic liposomes). Transmission electron microscopy showed ultrastructural features of absorption of magnetite nanoparticles. The shape, size, and number of vesicles containing nanoparticles in nephrocytes of convoluted tubules and macrophages after administration of the suspensions of magnetic nanospheres and magnetic liposomes were described.


Asunto(s)
Macrófagos/efectos de los fármacos , Nanopartículas de Magnetita/administración & dosificación , Células Mesangiales/efectos de los fármacos , Podocitos/efectos de los fármacos , Administración Intravenosa , Animales , Animales no Consanguíneos , Quitosano/química , Endocitosis , Liposomas/administración & dosificación , Macrófagos/metabolismo , Macrófagos/ultraestructura , Masculino , Células Mesangiales/metabolismo , Células Mesangiales/ultraestructura , Podocitos/metabolismo , Podocitos/ultraestructura , Ratas
13.
Adv Exp Med Biol ; 1006: 337-345, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28865030

RESUMEN

The central function of renal glomeruli is plasma ultrafiltration for primary urine production. The glomerular filtration barrier consists of a fenestrated endothelium, the glomerular basement membrane and podocytes, mesenchymal-like cells with actin filament-rich protrusions, the "foot processes." Their architecture and function are maintained and regulated by actin and several actin-binding proteins, mutations of which can be causative of glomerular diseases. Since initial immunostaining experiments had demonstrated intense drebrin reactions in renal glomeruli, the distribution of this protein was studied in detail in the kidneys of diverse mammalian species. Double-label confocal laser scanning microscopy revealed drebrin enrichment in mesangial cells of human, bovine, murine, and rat kidneys. In Thy-1.1 nephritic rat glomeruli, the protein was concentrated in mesangial cell processes and upregulated during their formation and remodeling. In adult human and bovine kidneys, drebrin was additionally accumulated in the foot processes of podocytes, a finding confirmed by immunoelectron microscopy. By contrast, podocytes of rodent glomeruli contained significant amounts of drebrin only during early developmental stages. In cultured murine podocytes induced to form cell processes, however, drebrin was concentrated in these protrusions, partly in colocalization with other actin-binding proteins. Protein extracts from human and bovine kidneys comprised 20 S-complexes of drebrin and actin, so-called drebrosomes. In summary, drebrin has to be added to the list of actin-binding proteins regulating actin dynamics of mesangial cell processes and foot processes of podocytes. It will be important to determine its role in hereditary and acquired glomerulopathies.


Asunto(s)
Glomérulos Renales/metabolismo , Proteínas de Microfilamentos/metabolismo , Nefritis/metabolismo , Neuropéptidos/metabolismo , Citoesqueleto de Actina/metabolismo , Animales , Humanos , Glomérulos Renales/patología , Glomérulos Renales/ultraestructura , Células Mesangiales/metabolismo , Células Mesangiales/ultraestructura , Ratones , Proteínas de Microfilamentos/genética , Microscopía Confocal , Nefritis/genética , Nefritis/patología , Neuropéptidos/genética , Podocitos/metabolismo , Podocitos/ultraestructura , Ratas
14.
Sci Rep ; 7(1): 11468, 2017 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-28904360

RESUMEN

Overlapping idiopathic membranous nephropathy (IMN) and immunoglobulin A nephropathy (IgAN) is rare. This study aims to investigate the unique prognostic, clinical, and renal histopathological characteristics of IMN+IgAN. This retrospective observational study included 73 consecutive cases of IMN+IgAN and 425 cases of IMN treated between September 2006 and November 2015. Prognostic and baseline clinical and histopathological data were compared between the two patient groups. Poor prognostic events included a permanent 50% reduction in eGFR, end-stage renal disease, and all-cause mortality. Renal histopathology demonstrated that the patients with IMN+IgAN presented with significantly increased mesangial cell proliferation and matrix expansion, increased inflammatory cell infiltration, and higher proportions of arteriole hyalinosis and lesions than the patients with IMN (all P < 0.05). Kaplan-Meier analysis showed that the patients with IMN+IgAN had significantly higher cumulative incidence rates of partial or complete remission (PR or CR, P = 0.0085). Multivariate Cox model analysis revealed that old age at biopsy and high baseline serum creatinine and uric acid levels were significantly associated with poor prognosis (all P < 0.05), and increased IgA expression correlated significantly with PR or CR (P < 0.05). The present study found that overlapping IMN and IgAN presents with unique renal histopathology and appears not to cause a poorer prognosis than IMN.


Asunto(s)
Glomerulonefritis por IGA/diagnóstico , Glomerulonefritis por IGA/mortalidad , Glomerulonefritis Membranosa/diagnóstico , Glomerulonefritis Membranosa/mortalidad , Riñón/patología , Adulto , Biomarcadores , Biopsia , Comorbilidad , Femenino , Técnica del Anticuerpo Fluorescente , Glomerulonefritis por IGA/etiología , Glomerulonefritis por IGA/metabolismo , Glomerulonefritis Membranosa/etiología , Glomerulonefritis Membranosa/metabolismo , Humanos , Inmunohistoquímica , Estimación de Kaplan-Meier , Pruebas de Función Renal , Masculino , Células Mesangiales/metabolismo , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Persona de Mediana Edad , Pronóstico
15.
Am J Physiol Renal Physiol ; 313(6): F1232-F1242, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-28835419

RESUMEN

Proteinuria has been reported in cancer patients receiving agents that target the transmembrane receptor neuropilin-1 (Nrp1) suggesting potential adverse effects on glomerular function. Here we show that Nrp1 is highly expressed by mesangial cells and that genetic deletion of the Nrp1 gene from PDGF receptor-ß+ mesangial cells results in proteinuric disease and glomerulosclerosis, leading to renal failure and death within 6 wk of age in mice. The major defect is a failure of mesangial cell migration that is required to establish the mature glomerular tuft. In vitro data show that the potent chemotactic effect of PDGFB is lost in Nrp1-deficient mesangial cells. Biochemical analyses reveal that Nrp1 is required for PDGFB-dependent phosphorylation of p130 Crk-associated substrate (p130Cas), a large-scaffold molecule that is involved in motility of other cell types. In stark contrast, matrix adhesion and activation of ERK and Akt, which mediate proliferation of mesangial cells in response to PDGFB, are unaffected by the absence of Nrp1. Taken together, these results identify a critical cell-autonomous role for Nrp1 in the migratory behavior of mesangial cells and may help explain the renal effects that occur in patients receiving Nrp1-inhibitory drugs.


Asunto(s)
Movimiento Celular , Glomerulonefritis/metabolismo , Células Mesangiales/metabolismo , Neuropilina-1/metabolismo , Proteinuria/metabolismo , Insuficiencia Renal/metabolismo , Animales , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Proteína Sustrato Asociada a CrK/metabolismo , Progresión de la Enfermedad , Predisposición Genética a la Enfermedad , Tasa de Filtración Glomerular , Glomerulonefritis/genética , Glomerulonefritis/patología , Glomerulonefritis/fisiopatología , Humanos , Células Mesangiales/efectos de los fármacos , Células Mesangiales/ultraestructura , Ratones Noqueados , Neuropilina-1/deficiencia , Neuropilina-1/genética , Fenotipo , Fosforilación , Proteinuria/genética , Proteinuria/patología , Proteinuria/fisiopatología , Proteínas Proto-Oncogénicas c-sis/farmacología , Interferencia de ARN , Insuficiencia Renal/genética , Insuficiencia Renal/patología , Insuficiencia Renal/fisiopatología , Transducción de Señal , Factores de Tiempo , Transfección
16.
Int J Mol Sci ; 18(2)2017 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-28208683

RESUMEN

Glomerular fibrosis has been shown to be closely related to the progression and prognosis of IgA nephropathy (IgAN). However, mechanism underlying IgAN glomerular fibrosis remains unclear. Recently, our study showed that plasma gelsolin (pGSN) was decreased in the serum of an IgAN mouse model and that pGSN deposition was found in the glomeruli. Another cytokine, TGF-ß1, which is closely related to glomerular fibrosis, was also found to be highly expressed in the glomeruli. In the present study, we report that pGSN induces glomerular fibrosis through the TGF-ß1/Smads signal transduction pathway. This is supported by the following findings: human mesangial cells (HMCs) show remarkable morphological changes and proliferation in response to co-stimulation with pGSN and polymeric IgA1 (pIgA1) from IgAN patients compared to other controls. Moreover, ELISA assays showed that more TGF-ß1 secretion was found in HMCs supernatants in the co-stimulation group. Further experiments showed increased TGF-ß1, Smad3, p-Smad2/3, Smad4, and collagen 1 and decreased Smad7 expression in the co-stimulation group. Our present study implied that the synergistic effect of pGSN and pIgA induced glomerular fibrosis via the TGF-ß1/Smads signal transduction pathway. This might be a potential mechanism for the glomerular fibrosis observed in IgAN patients.


Asunto(s)
Gelsolina/sangre , Glomerulonefritis por IGA/metabolismo , Glomerulonefritis por IGA/patología , Transducción de Señal , Proteínas Smad/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Biomarcadores , Estudios de Casos y Controles , Proliferación Celular , Fibrosis , Técnica del Anticuerpo Fluorescente , Glomerulonefritis por IGA/etiología , Humanos , Células Mesangiales/metabolismo , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Factor de Crecimiento Transformador beta1/sangre
17.
Am J Nephrol ; 45(4): 293-300, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28237991

RESUMEN

BACKGROUND: IgA nephropathy (IgAN) has been considered to be the most frequent form of primary glomerulonephritis that occurs worldwide with a variety of factors involved in its occurrence and development. The impact of autophagy in IgAN, however, remains partially unclear. This study was designed to investigate the effects of rapamycin in an IgAN model. METHOD: After establishing an IgAN rat model, SD rats were divided into 4 groups: control, control + rapamycin, IgAN, IgAN + rapamycin. Proteinuria and the pathological changes and the level of autophagy of kidney were texted. Identify the expression of phosphorylation and total mammalian target of rapamycin (mTOR) and s6k1 as well as cyclin D1 in the kidney of rats through Western blot and immunohistochemistry. RESULTS: With rapamycin treatment, we observed a significant reduction in the progression of proteinuria as well as alleviation of pathological lesions in IgAN rats. Besides, autophagy was inhibited, while the mTOR/S6k1 pathway was activated and expression of cyclin D1 was increased in IgAN. Rapamycin treatment increased autophagy and decreased the expression of cyclin D1. CONCLUSION: These results may suggest that mTOR-mediated autophagy inhibition may result in mesangial cell proliferation in IgAN.


Asunto(s)
Autofagia/efectos de los fármacos , Glomerulonefritis por IGA/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Células Mesangiales/patología , Transducción de Señal/efectos de los fármacos , Sirolimus/uso terapéutico , Animales , Proliferación Celular/efectos de los fármacos , Ciclina D1/metabolismo , Modelos Animales de Enfermedad , Glomerulonefritis por IGA/patología , Glomerulonefritis por IGA/orina , Humanos , Inmunohistoquímica , Células Mesangiales/efectos de los fármacos , Células Mesangiales/ultraestructura , Microscopía Electrónica , Proteinuria/tratamiento farmacológico , Proteinuria/orina , Ratas , Ratas Sprague-Dawley , Proteínas Quinasas S6 Ribosómicas/metabolismo , Serina-Treonina Quinasas TOR/metabolismo
18.
Diabetes ; 66(3): 763-778, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27899487

RESUMEN

The molecular signaling mechanisms between glomerular cell types during initiation/progression of diabetic kidney disease (DKD) remain poorly understood. We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 mice, but not in C57BL/6J, with comparable hyperglycemia. Diabetic D2 mice manifested increased mitochondrial DNA lesions (8-oxoguanine) exclusively localized to glomerular endothelial cells after 3 weeks of diabetes, and these accumulated over time in addition to increased urine secretion of 8-oxo-deoxyguanosine. Detailed assessment of glomerular capillaries from diabetic D2 mice demonstrated early signs of endothelial injury and loss of fenestrae. Glomerular endothelial mitochondrial dysfunction was associated with increased glomerular endothelin-1 receptor type A (Ednra) expression and increased circulating endothelin-1 (Edn1). Selective Ednra blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis. In human DKD, increased urine 8-oxo-deoxyguanosine was associated with rapid DKD progression, and biopsies from patients with DKD showed increased mitochondrial DNA damage associated with glomerular endothelial EDNRA expression. Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Nefropatías Diabéticas/metabolismo , Endotelina-1/metabolismo , Endotelio/metabolismo , Glomérulos Renales/metabolismo , Mitocondrias/metabolismo , Receptor de Endotelina A/metabolismo , 8-Hidroxi-2'-Desoxicoguanosina , Adulto , Anciano , Albuminuria , Animales , Antioxidantes/farmacología , Cromatografía Líquida de Alta Presión , ADN Mitocondrial/metabolismo , Desoxiguanosina/análogos & derivados , Desoxiguanosina/orina , Susceptibilidad a Enfermedades , Endotelio/efectos de los fármacos , Endotelio/ultraestructura , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Humanos , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/patología , Glomérulos Renales/ultraestructura , Masculino , Células Mesangiales/patología , Células Mesangiales/ultraestructura , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Microscopía Electrónica de Rastreo , Persona de Mediana Edad , Mitocondrias/efectos de los fármacos , Compuestos Organofosforados/farmacología , Consumo de Oxígeno , Piperidinas/farmacología , Podocitos/patología , Podocitos/ultraestructura , Reacción en Cadena en Tiempo Real de la Polimerasa , Transducción de Señal , Adulto Joven
19.
Cell Death Dis ; 7(11): e2445, 2016 11 03.
Artículo en Inglés | MEDLINE | ID: mdl-27809300

RESUMEN

The aim of our study was to investigate the role of autophagy, a homeostatic process involved in the lysosomal degradation of damaged cell organelles and proteins, in regulating the survival of mesangial cells treated with advanced glycation end products (AGEs). In the present study, AGEs induced mitochondrial depolarization and led to mitochondrial-dependent apoptosis in mesangial cells, as shown by the loss of the mitochondrial membrane potential; increased Bax processing; increased Caspase-9, Caspase-3 and PARP cleavage; and decreased Bcl-2 expression. Meanwhile, AGEs also triggered autophagy flux in mesangial cells, as confirmed by the presence of autophagic vesicles, the conversion of LC3II/LC3I and the increase/decrease in Beclin-1/p62 expression. Interestingly, this study reported apparent apoptosis and autophagy that were dependent on reactive oxygen species (ROS) production. Scavenging ROS with N-acetyl-l-cysteine could prevent the appearance of the autophagic features and reverse AGE-induced apoptosis. Moreover, AGE-triggered mitophagy, which was confirmed by the colocalization of autophagosomes and mitochondria and Parkin translocation to mitochondria, played a potential role in reducing ROS production in mesangial cells. Additionally, inhibition of autophagy significantly enhanced AGE-induced cell apoptosis. Taken together, our data suggest that ROS were the mediators of AGE-induced mesangial cell apoptosis and that autophagy was likely to be the mechanism that was triggered to repair the ROS-induced damage in the AGE-treated cells and thereby promote cell survival. This study provides new insights into the molecular mechanism of autophagy involved in AGE-induced apoptosis in mesangial cells.


Asunto(s)
Apoptosis , Autofagia , Productos Finales de Glicación Avanzada/metabolismo , Células Mesangiales/citología , Células Mesangiales/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Línea Celular , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Sistema de Señalización de MAP Quinasas , Potencial de la Membrana Mitocondrial , Células Mesangiales/ultraestructura , Mitocondrias/metabolismo , Mitofagia , Modelos Biológicos , Ratas , Transducción de Señal
20.
Cell Physiol Biochem ; 39(5): 1761-1776, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27744434

RESUMEN

BACKGROUND/AIMS: Individuals possessing a single kidney are at greater risk of renal injury upon exposure to harmful stimuli. This study aimed to explore the pathogenesis of renal injury in glomerulonephritis with versus without unilateral nephrectomy (UNX). METHODS: Histological analysis and label-free quantitative proteomics were performed on two models-the Habu snake venom-induced glomerulonephritis model with versus without UNX (HabuU and Habu models, respectively). The role of villin 1, a differentially expressed protein (DEP) in mouse mesangial cells, was investigated. RESULTS: Persistent mesangiolysis and focal hypercellularity together with reduced activation of cell proliferation in the HabuU model induced more serious renal injury compared with that in the Habu model. The DEPs between the two models were identified by label-free liquid chromatography-mass spectrometry. The KEGG pathway results indicated that regulation of actin cytoskeleton and focal adhesion were specifically enriched in the HabuU model. The cytoskeleton regulation protein villin 1 was downregulated in the HabuU model, but unchanged in the Habu model. Knockdown of villin 1 promoted apoptosis and inhibited the proliferation of mouse mesangial cells, suggesting villin 1 to be involved in qlomerular lesion self-repair insufficiency. CONCLUSION: By assessing the proteomic profiles of the two models, this study identified several important differences, particularly villin 1 expression, in regulatory mechanisms between the two models. Our findings provide novel insight into the mechanism of serious renal injury in glomerulonephritis with UNX.


Asunto(s)
Mesangio Glomerular/metabolismo , Glomerulonefritis/genética , Células Mesangiales/metabolismo , Nefrectomía , Proteómica , Venenos de Serpiente/toxicidad , Citoesqueleto de Actina/efectos de los fármacos , Citoesqueleto de Actina/metabolismo , Citoesqueleto de Actina/ultraestructura , Animales , Apoptosis/efectos de los fármacos , Modelos Animales de Enfermedad , Adhesiones Focales/efectos de los fármacos , Adhesiones Focales/metabolismo , Adhesiones Focales/ultraestructura , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Mesangio Glomerular/efectos de los fármacos , Mesangio Glomerular/cirugía , Mesangio Glomerular/ultraestructura , Glomerulonefritis/inducido químicamente , Glomerulonefritis/patología , Glomerulonefritis/cirugía , Humanos , Masculino , Células Mesangiales/efectos de los fármacos , Células Mesangiales/ultraestructura , Ratones , Ratones Endogámicos C57BL , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/metabolismo , Anotación de Secuencia Molecular , Cultivo Primario de Células
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...